Hi folks. What I am going to say won't help but I got to get it off of my mind.

I just re-read the Zenith proposal for Jan 7th. My reaction was the same as my original reaction which was "wonderful...they are in the process of protecting the royalty assets (of which I will be part of as a shareholder) and creating liquidity for my shares of Zenith Epigenetics and I will get that benefit as well as retain the royalty benefits".

Then I re-read the excellent posts by BDAZ, KOO, GV, fouremm, PVLee and others and then I realized that under this "name change" I do not have a clue of what I will own!

For example let us say that all of my shares end up being within Zenith Capital, which in turn, owns Zenith epigenetics and the RPS as separte entities. So I do not directly hold shares in Zenith Epigenetics (technology). Therefore I have no direct liquidity of my shares even if Zenith Epigenetics goes public unless Zenith Capital goes public (and what are the chances of that?).

So that's where I stand. Nothing I can do about it. I have no question with the science of ZENITH and I do believe that management has good intentions but when what they communicate is not crystal clear, and it should be unless they are hiding something, then I have concerns. Hopefully Jan 7th will provide clarity.

One impression I have from their announcement is that share liquidity is not in near sight.

So this is not a name change as per Sarah's reply...this is a restructuring and it is a first step toward something. If it is a step toward a series of Zenith Epigenetic IPOs, one for each platform, and if I have a pro-rated share position in every platform then I am a very happy person. As per masila's excellent summary from June Don was fairly committed to a Zenith IPO in Q4 of 2015. I hope this is part of that even if Q4 2015 was missed.

So then I tried to view this through a different prism. If this restructuring is approved, and it will be, then Eastern and NGN are in agreement. They hold 23,200,000 and 12,603,004 shares respectively in the current Zenith Epigenetics. Neither need a payback anytime soon. However, in masila's summary Don did say they are in constant discussions with potential licensees and others. Don and Dr Wong know their products. I've often thought of Zenith with it's platforms, patents and processes as a potential "epigenetic factory". For example a client comes to them with a specific need to produce a certain molecule and perhaps Zenith has the scaffold or can create the scaffold to produce that drug????

In other words perhaps Zenith's royalty stream is much closer than waiting for 4 or 5 years for rvx-208 to start filling the pipeline with big $????

Anyway, I'm drinking some rum with eggnog and about to put some decorations on the tree.

Sure hope Don brings a belated Christmas present to all of us in terms of a clean and simple pro-rated share structure along with liquidity.

I am not concerned about dilution (of course it depends on the depth) because if Don gets 1 platform of Zenith Epigenetics on the NASDAQ I'll be happy with what I get and look forward to many following platforms going public. And this of course course be the basis of Zenith Capital!

Have a great weekend.

Cheers

Toinv